| View |
|
DRP-8220-01
|
Diclofenac Sodium
|
Rinefen
|
50 mg
|
Enteric-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID’s)
|
Umedica Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
16 May 2024
|
18 March 2029
|
| View |
|
DRP-8246-01
|
Methotrexate
|
Pteribene
|
100 mg/mL (1000mg/10mL)
|
Solution for Injection (IM/IV)
|
Antineoplastic
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
19 May 2024
|
25 June 2027
|
| View |
|
DRP-8263-03
|
Mupirocin
|
Priadix
|
20 mg/g (2% w/w)
|
Ointment
|
Antibacterial
|
Magbro Healthcare Pvt. Ltd
|
India
|
Renewal
|
23 May 2024
|
10 July 2029
|
| View |
|
DRP-8263-04
|
Mupirocin
|
Tieradix
|
20 mg/g (2% w/w)
|
Ointment
|
Antibacterial
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Renewal
|
21 May 2024
|
10 July 2029
|
| View |
|
DRP-8351-05
|
Furosemide
|
Diufed
|
10 mg/mL (20mg/2mL)
|
Solution for Injection (I.M./I.V.)
|
Diuretic
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
20 May 2024
|
22 August 2029
|
| View |
|
DRP-8594-02
|
Ampicillin (as sodium)
|
Ampiden
|
500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
CLIDP Conversion
|
18 May 2024
|
20 December 2024
|
| View |
|
DRP-8637-12
|
Butamirate citrate
|
Ratepel
|
50 mg
|
Sustained-Release Tablet
|
Antitussives
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
19 May 2024
|
20 January 2025
|
| View |
|
DRP-8811-04
|
dl-Alpha Tocopherol Acetate (Vitamin E)
|
Anna-E
|
400 IU
|
Softgel Capsule
|
Vitamins
|
Kanion Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
19 May 2024
|
13 April 2025
|
| View |
|
DRP-8985-10
|
Losartan Potassium
|
Retazart
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
17 May 2024
|
21 July 2025
|
| View |
|
DRP-9084-03
|
Nicardipine Hydrochloride
|
Madexcard
|
1 mg/mL (10 mg/10 mL)
|
Solution for Injection (IV)
|
Calcium Channel Blocker
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
21 May 2024
|
24 August 2025
|
| View |
|
DRP-9136-05
|
Paracetamol
|
Ramgesic
|
150 mg/mL (300 mg/2mL)
|
Solution for Injection (I.M./I.V.)
|
Analgesic / Antipyretic
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
18 May 2024
|
11 September 2025
|
| View |
|
DRP-992-03
|
Fluocinolone Acetonide + Polymyxin B Sulfate + Neomycin (as Sulfate)
|
Pen-F
|
250 mcg/10,000 units/3.5 mg per mL
|
Otic Solution
|
Antibacterial / Corticosteroid
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 May 2024
|
16 May 2026
|
| View |
|
DRP-12213-06
|
Cefuroxime (as axetil)
|
Bacefur 500
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 July 2023
|
13 July 2027
|
| View |
|
DRP-12213-07
|
Cefuroxime (as axetil)
|
Cerin
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 July 2023
|
13 July 2027
|
| View |
|
DRP-12554-01
|
Omeprazole (as sodium)
|
Gomep IV
|
40mg
|
Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co. Ltd
|
China
|
CLIDP Conversion
|
22 March 2023
|
01 September 2027
|
| View |
|
DRP-10999-02
|
Cefepime (as hydrochloride)
|
Gofime
|
1g
|
Powder for Injection (I.M./I.V)
|
Antibacterial (Cephalosporin)
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
07 February 2023
|
31 December 2026
|
| View |
|
DRP-10888-01
|
Cefuroxime (As sodium)
|
Gocef IV
|
750 mg
|
Powder for Injection (I.V./I.M.)
|
Antibacterial (Cephalosporin)
|
Yeluri Formulations Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 February 2023
|
14 December 2026
|
| View |
|
DRP-10888-02
|
Cefuroxime (as Sodium)
|
Retazet-R
|
750 mg
|
Powder for Injection (I.M./I.V)
|
Antibacterial (Cephalosporin)
|
Yeluri Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
09 May 2023
|
14 December 2026
|
| View |
|
BR-1482
|
Heparin Sodium
|
Hepadur
|
5000 IU/mL
|
Solution for Injection (IV)
|
Antithrombotic agents
|
Tianjin Biochemical Pharmaceutical Co., Ltd
|
China
|
Renewal
|
27 May 2024
|
19 May 2029
|
| View |
|
DRP-10721-03
|
Dapagliflozin
|
Forfloz
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co- transporter 2 (SGLT2) inhibitor]
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
27 May 2024
|
11 November 2026
|